Teichmann Sarah A.
SEC Form 4 insider trading activity
Teichmann Sarah A. has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Aug 17, 2026.
On the most recent filing, Teichmann Sarah A. is listed as Director at 10x Genomics, Inc. Inside the rolling window, Teichmann Sarah A. reported no open-market purchases and 2 open-market sales totaling $432K in TXG. The largest disclosed transaction in the window is a sale of 5,278 TXG shares on Aug 13, 2026, worth $302K.
Companies traded
Other insiders at TXG
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$432K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Teichmann Sarah A. made?
Teichmann Sarah A. has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company since 2026.
Which companies does Teichmann Sarah A. trade?
Teichmann Sarah A. has filed SEC Form 4 disclosures for 1 company, including TXG.
When was Teichmann Sarah A.'s most recent SEC Form 4 filing?
Teichmann Sarah A.'s most recent SEC Form 4 filing on Tracefour is dated Aug 17, 2026.
What is Teichmann Sarah A.'s total buy and sell value in the current window?
Inside the rolling retention window, Teichmann Sarah A. bought $0 and sold $432K based on SEC Form 4 filings.
What was Teichmann Sarah A.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 5,278 TXG shares on 2026-08-13, worth $302K, per SEC Form 4 filings.